🇺🇸 TAKHZYRO in United States

TAKHZYRO (LANADELUMAB-FLYO) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

TAKHZYRO in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is TAKHZYRO approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for TAKHZYRO in United States?

DYAX CORP. is the originator. The local marketing authorisation holder may differ — check the official source linked above.